Purchases and Sales Made in Q3 2021 in Acelrx Pharmaceuticals Inc (ACRX)
This table provides information about the institutional ownership of Acelrx Pharmaceuticals Inc (ACRX) during Q3 2021. The information is specifically focused on institutions that hold shares of ACELRX PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-65.6K- 6.24% |
$61K - $99K
|
985K
$1.11M
|
|
|
Nov 10, 2021
Q3 2021
|
Robertson Stephens Wealth Management, LLC
San Francisco, CA |
SELL
|
- |
-88.8K- 39.88% |
$82.6K - $134K
|
134K
$151K
|
|
|
Nov 15, 2021
Q3 2021
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-148K- 34.42% |
$138K - $224K
|
282K
$319K
|
|
|
Nov 15, 2022
Q3 2021
|
Values First Advisors, Inc.
|
SELL
|
- |
-283K- 36.92% |
$263K - $428K
|
484K
$547K
|
|
|
Nov 15, 2021
Q3 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.28M- 84.27% |
$1.19M - $1.93M
|
239K
$270K
|
|
|
Nov 15, 2021
Q3 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.45M- 30.5% |
$1.35M - $2.2M
|
3.31M
$3.74M
|